Leerink Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Leerink partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Leerink Partners Today - Breaking & Trending Today

FDA advisors recommend Eli Lilly Alzheimer's drug donanemab

If approved, Eli Lilly's donanemab would become the second Alzheimer's drug of its kind currently on the U.S. market after Leqembi from Biogen and Eisai. ....

United States , Mark Mintun , Sarah Dolan , David Risinger , Eli Lilly , Drug Administration On , Critical Path Institute , Drug Administration , Leerink Partners ,